RxDoctor Payments Data

William Stohl

Rheumatology · Los Angeles, CANPI 1225230477

Payments from drug & device makers

$306,440in general payments, 2019–2025

Across 101 payments — averaging $3034.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$159K
  • GSK$42K
  • Janssen Research & Development, LLC$32K
  • E.r. Squibb & Sons, L.L.C.$23K
  • Novartis$22K
  • Kiniksa Pharmaceuticals, Ltd.$20K
  • plus $8K from 1 others
$84in research payments, 2019–2025

Across 1 payment — averaging $84.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$84

What the payments were for

  • Consulting fees$4,03097%
  • Travel & lodging$241%
  • Food & beverage$1223%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$306,440 in reported general payments places this provider in the 90th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California

Other rheumatology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →